KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Income from Continuing Operations (2016 - 2025)

Medpace Holdings' Income from Continuing Operations history spans 11 years, with the latest figure at 135133000.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations rose 15.48% year-over-year to 135133000.0; the TTM value through Dec 2025 reached 451123000.0, up 11.56%, while the annual FY2025 figure was 451123000.0, 11.56% up from the prior year.
  • Income from Continuing Operations reached 135133000.0 in Q4 2025 per MEDP's latest filing, up from 111135000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 135133000.0 in Q4 2025 to a low of 39934000.0 in Q2 2021.
  • Average Income from Continuing Operations over 5 years is 78276750.0, with a median of 71722000.0 recorded in 2023.
  • The largest YoY upside for Income from Continuing Operations was 65.67% in 2021 against a maximum downside of 1.64% in 2021.
  • A 5-year view of Income from Continuing Operations shows it stood at 50034000.0 in 2021, then soared by 37.25% to 68670000.0 in 2022, then increased by 14.02% to 78298000.0 in 2023, then skyrocketed by 49.45% to 117018000.0 in 2024, then grew by 15.48% to 135133000.0 in 2025.
  • Per Business Quant, the three most recent readings for MEDP's Income from Continuing Operations are 135133000.0 (Q4 2025), 111135000.0 (Q3 2025), and 90260000.0 (Q2 2025).